In the News


Celebrate National Internal Medicine Day on Oct. 28

Join with ACP and share your pride in internal medicine physicians' essential role in health care with social media posts, profile frames, and a Twitter chat.

Apixaban safer, more effective than rivaroxaban for afib with heart disease, study finds

Apixaban was associated with a lower rate of ischemic stroke or systemic embolism and a lower rate of bleeding in a propensity-matched cohort study of commercially insured patients with atrial fibrillation (AF) and valvular heart disease.

MKSAP Quiz: Left-sided facial weakness

A 36-year-old woman is evaluated for left-sided facial weakness. Over the last 10 days she has developed progressive weakness on the left side of her face, which is apparent with eye closure, smiling, and chewing. She has also reduced tearing and diplopia. Following a physical exam, what is the most appropriate next step in management?

European trial finds reduction in cancers but not deaths with invitation to colonoscopy screening

Healthy patients in Poland, Norway, and Sweden were randomized to usual care or an invitation to screening colonoscopy; only 42% of invited patients responded. The invited group had an 18% lower risk of colorectal cancer at 10 years compared to the usual care group.

ACP, Annals of Internal Medicine host ‘Monkeypox: Challenging Clinical Questions'

The virtual forum featured a panel of physicians providing answers to commonly asked questions about the human monkeypox virus and is available for replay online.

New trials provide data to improve medication management in hypertension

A U.K. study compared morning versus evening dosing of antihypertensive drugs, a U.S. study looked at optimal dosing in patients with proteinuria, and a trial in Spain tested self-titration in patients with poorly controlled hypertension.

And the winner is …

ACP Internist Weekly has tallied the voting from its latest cartoon contest, where readers are invited to match wits against their peers to provide the most original and amusing caption.